Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국
수요일, 9월 09

Anavex Life Sciences Corp

AVXLNASDAQ
Trade with Public
Trade with Public
$2.85
-0.01-0.35%
가까이에: Sep 8, 5:00 PM EST
$2.84
-0.01-0.35%
시간외: 4:45 PM EST
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교옵션주식 보고서

Anavex Life Sciences Financials

Anavex Life Sciences (AVXL) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Anavex Life Sciences Q3 EPS $0.08 Beats $(0.08) Estimate

Anavex Life Sciences (NASDAQ:AVXL) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $(0.08) by 200 percent. This is a 150 percent increase over losses of $(0.16) per share from
Benzinga Newsdesk

PRO
Anavex Life Sciences Q2 EPS $(0.06) Beats $(0.08) Estimate

Anavex Life Sciences (NASDAQ:AVXL) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.08) by 25 percent. This is a 53.85 percent increase over losses of $(0.13) per share
Benzinga Newsdesk

PRO
Anavex Life Sciences Reports Preliminary Q2 Net Loss Of $0.06 Per Share vs. $0.13 A Year Ago; $127.4M Cash Funds Operations Into Mid-To-Late Fiscal 2028

Benzinga Newsdesk

PRO
Anavex Life Sciences Q1 EPS $(0.06) Beats $(0.11) Estimate

Anavex Life Sciences (NASDAQ:AVXL) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.11) by 45.45 percent. This is a 57.14 percent increase over losses of $(0.14) per share
Benzinga Newsdesk

Earnings Scheduled For February 9, 2026

Benzinga Insights

Anavex Life Sciences's Earnings Outlook

Benzinga Insights

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

Benzinga

Benzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved